Activation of sclerostin inhibits Isg20-Mediated aerobic glycolysis ameliorating renal Fibrosis: the renoprotective mechanism of hederagenin in CKD
Sclerostin (Sost) functions as an inhibitor of the Wnt/β-catenin signaling pathway, which is known to promote kidney cell epithelial-to-mesenchymal transition (EMT), and fibrosis in chronic kidney disease (CKD). However, the renoprotective effects of Sost in kidney diseases and its therapeutic poten...
Saved in:
Main Authors: | Rang-yue Han, Rui-zhi Tan, Ling-hui Xu, Jing-yi Lin, Tong Li, Hong-wei Su, Ping Li, Peng Liu, Hui-yao Lan, Li Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-09-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725002757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity
by: Lu M, et al.
Published: (2025-07-01) -
Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis
by: Lingzhi Huang, et al.
Published: (2025-06-01) -
ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01) -
Ultrasound combined with microbubble enhanced renoprotective effects of NLRP3 inflammasome inhibitor MCC950 in CKD model
by: Wen Wen, et al.
Published: (2025-07-01) -
Prevalence of dysmagnesemia among CKD patients in North India
by: Shailata Prisi, et al.
Published: (2025-03-01)